Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$2.28 - $6.81 $91 - $272
-40 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$1.91 - $2.67 $76 - $106
40 New
40 $0
Q3 2020

Oct 20, 2020

SELL
$1.67 - $4.67 $41 - $116
-25 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$0.65 - $2.6 $16 - $65
25 New
25 $0

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $35.3M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Joseph P. Lucia & Associates, LLC Portfolio

Follow Joseph P. Lucia & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.